Cite
MLA Citation
Indira Sahdev et al.. “Timing of Alemtuzumab With Respect to Day of Bone Marrow Infusion and its Effects Upon Engraftment and Graft-Versus-Host Disease in Patients With Sickle Cell Disease.” Journal of pediatric hematology/oncology, vol. 42, no. 8, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100152019278.0x00001c